The US FDA proposed on April 30, 2026, to exclude key ingredients like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide from the 503B...
United States President Donald Trump has launched TrumpRx.gov, a self-branded website linking Americans to steep discounts on prescription drugs, including GLP-1 weight-loss treatments from...